Report overview
Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality.
This report aims to provide a comprehensive presentation of the global market for Intravenous Iron Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Iron Drugs. This report contains market size and forecasts of Intravenous Iron Drugs in global, including the following market information:
Global Intravenous Iron Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Intravenous Iron Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Intravenous Iron Drugs companies in 2022 (%)
The global Intravenous Iron Drugs market was valued at US$ 1491.1 million in 2022 and is projected to reach US$ 1952.2 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Treatment with intravenous iron is clearly superior to oral iron and presents several advantages such as faster and higher increase in Hb levels and replenishment of body iron stores. For these reasons, modern formulations of IV iron have emerged as safe and effective alternatives for IDA management.
We surveyed the Intravenous Iron Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous Iron Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intravenous Iron Drugs Market Segment Percentages, by Type, 2022 (%)
Ferric Gluconate
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Global Intravenous Iron Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intravenous Iron Drugs Market Segment Percentages, by Application, 2022 (%)
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
Global Intravenous Iron Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intravenous Iron Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous Iron Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Intravenous Iron Drugs revenues share in global market, 2022 (%)
Key companies Intravenous Iron Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Intravenous Iron Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
AMAG Pharmaceuticals
Daiichi Sankyo
Galenica
Pharmacosmos
Nippon Shinyaku
NOXXON Pharma
Rockwell Medical
Sanofi
Wanbang Biopharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intravenous Iron Drugs, market overview.
Chapter 2: Global Intravenous Iron Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Intravenous Iron Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intravenous Iron Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intravenous Iron Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
